Targeting the Ubiquitin-Proteasome System to Selectively Degrade LSD1
The persistent overexpression of the lysine-specific demethylase 1 (LSD1) enzyme has been notoriously linked to poor clinical outcomes across a...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
The persistent overexpression of the lysine-specific demethylase 1 (LSD1) enzyme has been notoriously linked to poor clinical outcomes across a...
In a groundbreaking study poised to reshape the understanding of aggressive thyroid cancer, researchers have unveiled significant insights into the...
A groundbreaking review titled “Targeted therapies and resistance mechanisms in lymphoma: Current landscape and emerging solutions” was published in the...
In a remarkable stride toward advancing treatments for life-threatening diseases, the City of Hope research community has unveiled a series...
In a groundbreaking advancement in oncology and immunotherapy, researchers have unveiled a novel approach to predict patient responses to immune...
In a groundbreaking review published in the esteemed journal "Pediatric Radiology," a team of researchers led by Dasic et al....
In the world of oncology, understanding drug resistance is as crucial as the efficacy of the treatment itself. A recent...
In the relentless pursuit to amplify the efficacy of cancer immunotherapy, a pivotal discovery has emerged illuminating the intricate regulation...
In recent years, the landscape of cancer research has been notably transformed by technological advancements, particularly in the realm of...
In the evolving landscape of cancer immunotherapy, the quest for novel immune checkpoint targets has never been more urgent. Conventional...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine